Clinical Trial Update: Trial of Radiation and Gene Therapy Before Nivolumab for Metastatic Non-Small Cell Lung Carcinoma and Uveal Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating radiation and gene therapy before nivolumab in metastatic non-small cell lung cancer and uveal melanoma was terminated; results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Squamous Cell Carcinoma
• Non-small Cell Lung Cancer
• Uveal Melanoma

Drugs mentioned

• Gene Therapy
• Radiation therapy
• nivolumab (nivolumab)

Snippet

Sponsor: Eric Bernicker, MD | Conditions: Lung Squamous Cell Carcinoma Stage IV, Nonsquamous Nonsmall Cell Neoplasm of Lung | Phase 2 | Status: TERMINATED | Results posted: 2023-09-21